effects of Acarbose on type 1 diabetes mellitus

effects of acarbose in metabolic control of patients with diabetes mellitus

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201102165844N1

Enrollment

Registered

2011-04-17

Start date

2010-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes mellitus. Insulin-dependent diabetes mellitus

Interventions

Intervention 1: acarbose administration 25 mg TDS 2 weeks then 50mg 10 weeks. Intervention 2: placebo administration 25 mg TDS 2 weeks then 50mg 10 weeks.

Treatment - Drugs

Placebo

acarbose administration 25 mg TDS 2 weeks then 50mg 10 weeks

placebo administration 25 mg TDS 2 weeks then 50mg 10 weeks

Eligibility

Sex/Gender

All

Age

No minimum to 30 Years

Inclusion criteria

Inclusion criteria: inclusion criteria :type 1 diabetes, at least from 1years before & HbA1C =7.5% ,exclusion criteria: Cr = 2 , partial GI obstruction,IBD .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post prandial glucose. Timepoint: 2 hours after each meal. Method of measurement: laboratory kit and Saccharimeter.	—

Secondary

Measure	Time frame
HbA1C. Timepoint: monthly. Method of measurement: laboratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShiva Shahnazari

Qazvin University of Medical Science

dr.shahnazari.sh@gmail.com+98 21 8833 5514

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 10, 2026